Should I buy or sell Fresenius SE & Co. KGaA stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Fresenius SE & Co. KGaA in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" FSNUY shares. View FSNUY analyst ratings or view top-rated stocks .

How have FSNUY shares performed in 2024?

Fresenius SE & Co. KGaA's stock was trading at $7.7250 at the start of the year. Since then, FSNUY shares have decreased by 5.5% and is now trading at $7.30. View the best growth stocks for 2024 here .

Are investors shorting Fresenius SE & Co. KGaA?

Fresenius SE & Co. KGaA saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 11,000 shares, a drop of 29.5% from the March 15th total of 15,600 shares. Based on an average daily trading volume, of 69,400 shares, the days-to-cover ratio is currently 0.2 days. View Fresenius SE & Co. KGaA's Short Interest .

How were Fresenius SE & Co. KGaA's earnings last quarter?

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) released its quarterly earnings results on Thursday, May, 6th. The company reported $0.24 EPS for the quarter, topping analysts' consensus estimates of $0.23 by $0.01. The company had revenue of $10.83 billion for the quarter. Fresenius SE & Co. KGaA had a net margin of 0.71% and a trailing twelve-month return on equity of 4.88%.

How often does Fresenius SE & Co. KGaA pay dividends? What is the dividend yield for Fresenius SE & Co. KGaA?

Fresenius SE & Co. KGaA declared a dividend on Saturday, May 13th. Investors of record on Friday, May 19th will be paid a dividend of $0.1672 per share on Tuesday, May 30th. This represents a yield of 2.4%. The ex-dividend date of this dividend is Thursday, May 18th. Read our dividend analysis for FSNUY .

Is Fresenius SE & Co. KGaA a good dividend stock?

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) pays an annual dividend of $0.17 per share and currently has a dividend yield of 2.34%. The dividend payout ratio is 154.56%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, FSNUY will have a dividend payout ratio of 16.67% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for FSNUY .

How do I buy shares of Fresenius SE & Co. KGaA?

Shares of FSNUY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:FSNUY

Fresenius SE & Co. KGaA (FSNUY) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free FSNUY Stock Alerts

$7.30

+0.19 (+2.67%)

(As of 05:38 PM ET)

Compare

Today's Range: $7.17
▼
$7.30
50-Day Range: $6.63
▼
$7.14
52-Week Range: $6.33
▼
$8.38

Volume: 43,640 shs
Average Volume: 42,170 shs
Market Capitalization: $16.31 billion

P/E Ratio: 66.37
Dividend Yield: 2.33%
Price Target: N/A

Stock Analysis Analyst Forecasts Chart Dividend Earnings Headlines Short Interest

Get Fresenius SE & Co. KGaA alerts:

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

About Fresenius SE & Co. KGaA Stock (OTCMKTS:FSNUY)

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.

FSNUY Stock Price History

30 days | 90 days | 365 days | Advanced Chart

FSNUY Stock News Headlines

April 19, 2024 | wsj.com

Fresenius SE & Co. KGaA ADR

April 16, 2024 | finance.yahoo.com

UPDATE 1-STOXX 600 nears six-week low on geopolitical jitters; Ericsson shines

April 19, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

April 4, 2024 | finance.yahoo.com

Is Now The Time To Look At Buying Fresenius SE & Co. KGaA (ETR:FRE)?

March 8, 2024 | marketwatch.com

Fresenius Extends Contract of Finance Chief Sara Hennicken

February 21, 2024 | msn.com

Germany's Fresenius slips into red after unbundling of dialysis unit

February 21, 2024 | reuters.com

Healthcare group Fresenius tops Q4 operating profit expectations

February 20, 2024 | msn.com

Fresenius Medical Care Non-GAAP EPS of €0.88, revenue of €4.99B; initiates FY24 outlook

April 19, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

February 20, 2024 | markets.businessinsider.com

Fresenius Medical Care Q4 Profit Climbs, Lifts Dividend; Sees Growth In FY24; Backs FY25 View

February 20, 2024 | marketwatch.com

Fresenius Medical Care 4Q Net Pft EUR188M

February 5, 2024 | msn.com

Cigna upgraded at Cantor, RBC on Q4 results, Medicare sale

January 15, 2024 | msn.com

Fresenius perfectly positioned to combat health inequality, says CEO

January 8, 2024 | marketwatch.com

Fresenius Medical Care to Get About $547 Mln From Asset Sales

December 15, 2023 | finance.yahoo.com

Fresenius SE & Co. KGaA (FSNUY)

December 8, 2023 | msn.com

Fresenius plans to sell rehabilitation care clinics - FAZ

December 6, 2023 | msn.com

Fresenius Medical Care says data on 500,000 people stolen in U.S.

December 6, 2023 | marketwatch.com

Fresenius Suspends 2023 Dividend After Using German Relief Package

December 6, 2023 | msn.com

Fresenius Medical Care says data on 500,000 people stolen in U.S

November 28, 2023 | entrepreneur.com

Top 3 Medical Stocks Diagnosing Weekly Potential for Profit

November 22, 2023 | markets.businessinsider.com

Fresenius Medical Care Enters Into Settlement Agreement With U.S.; Raises Annual Earnings Outlook

November 22, 2023 | finance.yahoo.com

Individual investors account for 43% of Fresenius SE & Co. KGaA's (ETR:FRE) ownership, while institutions account for 30%

November 8, 2023 | marketwatch.com

Fresenius Sells Eugin to Private-Equity Consortium for Up to $535 Mln

November 5, 2023 | finance.yahoo.com

Analysts Just Shaved Their Fresenius SE & Co. KGaA (ETR:FRE) Forecasts Dramatically

November 2, 2023 | markets.businessinsider.com

Fresenius Group Q3 Group EBIT Before Items Rises, Revenue Growth At 6%; Improves FY EBIT Guidance

November 2, 2023 | msn.com

We need data to see the efficacy of Novo Nordisk's weight-loss drug, Fresenius CEO says

November 2, 2023 | markets.businessinsider.com

EQS-Adhoc: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care AG & Co. KGaA raises outlook for operating income in fiscal year 2023

See More Headlines

Receive FSNUY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius SE & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 5/06/2021
Today: 4/19/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Surgical & medical instruments
Sub-Industry: N/A
Current Symbol: OTCMKTS:FSNUY
CUSIP: N/A
CIK: N/A
Web: www.fresenius.com
Phone: (496) 172-6080
Fax: N/A
Employees: 316,920
Year Founded: 1912

Profitability

EPS (Most Recent Fiscal Year): $0.11
Trailing P/E Ratio: 66.37
Forward P/E Ratio: 8.39
P/E Growth: N/A
Net Income: $-639,610,000.00
Net Margins: 0.71%
Pretax Margin: 4.80%
Return on Equity: 4.88%
Return on Assets: 2.02%

Debt

Debt-to-Equity Ratio: 0.36
Current Ratio: 1.54
Quick Ratio: 1.44

Sales & Book Value

Annual Sales: $24.01 billion
Price / Sales: 0.68
Cash Flow: $2.24 per share
Price / Cash Flow: 3.26
Book Value: $15.07 per share
Price / Book: 0.48

Miscellaneous

Outstanding Shares: 2,234,010,000
Free Float: N/A
Market Cap: $16.31 billion
Optionable: Not Optionable
Beta: 1.12

Social Links

Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

Mr. Michael Sen (Age 56)
CEO, President & Chairman of Management Board - Fresenius Management SE
Comp: $4.34M
Ms. Sara Lisa Hennicken (Age 44)
CFO & Member of the Management Board - Fresenius Management SE
Comp: $1.64M
Mr. Pierluigi Antonelli
Member of Management Board of Fresenius Management SE & CEO of Fresenius Kabi
Dr. Michael Sven Moser Ph.D. (Age 46)
Member of Management Board of Fresenius Management SE
Comp: $1.27M
Mr. Robert Moller (Age 53)
Member of the Management Board of Fresenius Management SE
Comp: $1.22M
Mr. Markus Georgi
Senior Vice President of Investor Relations
Matthias Link
Senior Vice President Corporate Communications

Key Competitors

View All Competitors

FSNUY Stock Analysis - Frequently Asked Questions

Should I buy or sell Fresenius SE & Co. KGaA stock right now?: 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Fresenius SE & Co. KGaA in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" FSNUY shares.
View FSNUY analyst ratings or view top-rated stocks.
How have FSNUY shares performed in 2024?: Fresenius SE & Co. KGaA's stock was trading at $7.7250 at the start of the year. Since then, FSNUY shares have decreased by 5.5% and is now trading at $7.30.
View the best growth stocks for 2024 here.
Are investors shorting Fresenius SE & Co. KGaA?: Fresenius SE & Co. KGaA saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 11,000 shares, a drop of 29.5% from the March 15th total of 15,600 shares. Based on an average daily trading volume, of 69,400 shares, the days-to-cover ratio is currently 0.2 days.
View Fresenius SE & Co. KGaA's Short Interest.
How were Fresenius SE & Co. KGaA's earnings last quarter?: Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) released its quarterly earnings results on Thursday, May, 6th. The company reported $0.24 EPS for the quarter, topping analysts' consensus estimates of $0.23 by $0.01. The company had revenue of $10.83 billion for the quarter. Fresenius SE & Co. KGaA had a net margin of 0.71% and a trailing twelve-month return on equity of 4.88%.

How often does Fresenius SE & Co. KGaA pay dividends? What is the dividend yield for Fresenius SE & Co. KGaA?: Fresenius SE & Co. KGaA declared a dividend on Saturday, May 13th. Investors of record on Friday, May 19th will be paid a dividend of $0.1672 per share on Tuesday, May 30th. This represents a yield of 2.4%. The ex-dividend date of this dividend is Thursday, May 18th.
Read our dividend analysis for FSNUY.
Is Fresenius SE & Co. KGaA a good dividend stock?: Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) pays an annual dividend of $0.17 per share and currently has a dividend yield of 2.34%. The dividend payout ratio is 154.56%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, FSNUY will have a dividend payout ratio of 16.67% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for FSNUY.
How do I buy shares of Fresenius SE & Co. KGaA?: Shares of FSNUY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:FSNUY) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial